Efficacy and Safety of Pulmonary Function Analysis With Dynamic Digital Radiography Total Respiratory Cycle Photography

October 3, 2022 updated by: Shenzhen People's Hospital

Efficacy and Safety of Pulmonary Function Analysis With Dynamic Digital Radiography Total Respiratory Cycle Photography in Healthy Volunteers

The digital X-ray system produced by Shenzhen Angell Technology Co., Ltd was selected as the tested equipment, and the powerlab biological signal acquisition and analysis system equipped with a pneumotachograph by ADInstruments was selected as the reference equipment. During the study, the lung volume measurements obtained by the lung function analysis method based on the dynamic digital radiography full respiratory cycle photography of the tested equipment was compared with the lung volume measurements obtained by the reference device pneumotachograph. The consistency of the lung volume measurements was used as the main validity evaluation index to observe the distribution of the differences between the measured values of the test device and the reference device, and to verify the validity of the declared product according to the main validity evaluation index.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Pulmonary function test is a test to explore the functional status of human respiratory system with the knowledge of exercise respiratory physiology and modern examination technology. It is an important test content for clinical diagnosis, severity assessment, treatment and prognosis assessment of chest and lung diseases, which has been widely used in the fields of respiratory medicine, surgery and anesthesiology. Compared with chest X-rays and CT examinations, which reflect the static function of the chest and lungs, pulmonary function tests can better reflect the dynamic functional changes of the body.

However, pulmonary function test is not well performed to assess the functional status in patients with poor cooperation (e.g., poor lung function, inability to understand cooperation). Dynamic digital X-ray whole respiratory cycle photography uses advanced dynamic radiography and acquisition technology to obtain high-definition dynamic lung images during the whole respiratory cycle of the patient, and uses the industry's first rotating foot pedal to rotate the patient to obtain weighted 3D scan data and single-angle or multi-angle lung data. The patient's lung function is analyzed by algorithmically extracting the patient's full respiratory cycle airway nodes and branches and data statistics. For patients who cannot cooperate with the lung function, it can provid information on the dynamic function of the patient's chest and lungs for doctors to further improve clinical diagnosis and treatment.

At present, the digital X-ray system (DTP580B-3) and the patient position fixation frame MRW-P1 manufactured by Shenzhen Angell Technology Co., Ltd. have passed the inspection by the inspection agency certified by the State Drug Administration of China (NMPA). Clinical trials were conducted to further evaluate the clinical effectiveness and safety of the products.

The lung volume was measured using a pneumotachograph (with a physiological signal recorder) and a digital X-ray system (UC dynamic DR) in the same healthy subject, and the lung volume values measured by each of the reference device were analyzed for consistency to evaluate the validity of the lung volume measurement by the test device. And To evaluate the safety of the lung volume measurement function of the test device in clinical use based on the occurrence of device malfunctions, adverse events and serious adverse events in the trial.

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

① age ≥ 18 years; ② subjects willing to undergo chest radiography; ③ normal pulmonary ventilation function (forced vital capacity (FVC) ≥ 80% of the expected value; forced expiratory volume in first second (FEV1) ≥ 80% of the expected value; 1 second rate (FEV1/FVC) ≥ 70%); ④ can perform tidal breathing, deep inspiration and deep expiration; ⑤ no history of smoking; ⑥ no history of chronic respiratory disease; ⑦ no acute respiratory disease within 4 weeks; ⑧ subjects willing to provide written informed consent

Exclusion Criteria:

① Pregnant and lactating women; ② Inability to stand alone; ③ Severe vertigo and other adverse reactions to rotation in place.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Pneumotachograph
The subject stood on the turntable of the instrument and grasped the postural fixator with both hands up. The subjects pinched their nose and breathed through the disposable filter mouthpiece connected to the pneumotachograph, taking care not to leak air at the corners of the mouth. The subjects were instructed to perform tidal breathing, deep inhalation, deep exhalation, etc., and to monitor lung volume by pneumotachograph.
The pneumotachograph monitors the flow rate, and the lung volume is calculated by integrating.
Experimental: Dynamic digital radiography
The subject stood on the turntable of the instrument and grasped the postural fixator with both hands up. The subjects pinched their nose and breathed through the disposable filter mouthpiece connected to the pneumotachograph, taking care not to leak air at the corners of the mouth. The subjects were instructed to perform tidal breathing, deep inhalation, deep exhalation, etc., and to monitor lung volume by dynamic digital radiography analysis.
The use of advanced dynamic X-ray photography and acquisition technology can obtain high-definition dynamic lung images of patients throughout the respiratory cycle for analysis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lung volume changes
Time Frame: 1 day (The start time is when the subject is positioned and begins to breathe on command, and the end time is when the subject safely exits the x-ray system.)
The volume of gas inhaled/exhaled during each respiratory session of the subject during the monitoring period.
1 day (The start time is when the subject is positioned and begins to breathe on command, and the end time is when the subject safely exits the x-ray system.)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Rongchang Chen, PhD, ShenZhen People's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 20, 2022

Primary Completion (Anticipated)

July 20, 2023

Study Completion (Anticipated)

October 20, 2023

Study Registration Dates

First Submitted

September 30, 2022

First Submitted That Met QC Criteria

October 3, 2022

First Posted (Actual)

October 4, 2022

Study Record Updates

Last Update Posted (Actual)

October 4, 2022

Last Update Submitted That Met QC Criteria

October 3, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 202101-02

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Pneumotachograph

3
Subscribe